BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/13/2018 8:32:30 AM | Browse: 995 | Download: 2036
 |
Received |
|
2017-12-11 14:43 |
 |
Peer-Review Started |
|
2017-12-12 02:42 |
 |
First Decision by Editorial Office Director |
|
2017-12-26 20:27 |
 |
Return for Revision |
|
2017-12-27 09:31 |
 |
Revised |
|
2017-12-31 16:22 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2018-01-23 10:11 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2018-01-23 22:43 |
 |
Articles in Press |
|
2018-01-23 22:43 |
 |
Edit the Manuscript by Language Editor |
|
2018-02-07 03:32 |
 |
Typeset the Manuscript |
|
2018-03-09 09:48 |
 |
Publish the Manuscript Online |
|
2018-03-13 08:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shakuntala Santosh Chopade and Suneela Sunil Dhaneshwar |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Women Scientist Scheme-A (WOS-A) (DST) |
SR/WOS-A/ LS-1115/2014 |
|
| Corresponding Author |
Suneela Sunil Dhaneshwar, BPharm, PhD, Professor, Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University, Pune 411038, India. suneeladhaneshwar@rediffmail.com |
| Key Words |
Mycophenolic acid; Mutual prodrug; Inflammatory bowel disease; Mycophenolate mofetil |
| Core Tip |
Mycophenolic acid (MPA), an immunosuppressant and its morpholinoethyl ester prodrug: mycophenolate mofetil are under investigation for the treatment of inflammatory bowel disease (IBD). Diarrhea and local gut toxicity are their major setbacks. Present work was focused on synthesizing colon-targeted prodrugs wherein MPA was bio-reversibly linked with aminosugars to mask carboxyl group of MPA responsible for gastrointestinal side effects. Synthesized prodrugs exhibited a significant mitigating outcome on 2,4,6-trinitrobezenesulfonic acid- induced colitis in Wistar rats compared to MPA. Absence of pancreatitis, hepatitis and gastro-sparing nature of the prodrugs emphasize their potential which could be reconnoitered further for management of IBD. |
| Publish Date |
2018-03-13 08:32 |
| Citation |
Choapade SS, Dhaneshwar SS. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats. World J Gastroenterol 2018; 24(10): 1093-1106 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i10/1093.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i10.1093 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.